NaomiS(Haas)BalzerMD
Oncology • Philadelphia, PAGenitourinary Oncology, Hematologic Oncology, Melanoma
Director, Prostate and Kidney Cancer Program; Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Dr. Balzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-615-5858- Is this information wrong?
Education & Training
Temple University HospitalFellowship, Hematology and Medical Oncology, 1988 - 1991
Abington Memorial HospitalResidency, Internal Medicine, 1985 - 1988
Northeast Ohio Medical UniversityClass of 1985
Certifications & Licensure
PA State Medical License 1986 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 1999 Jun 01
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer Start of enrollment: 2002 Oct 01
- Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma Start of enrollment: 2004 Feb 24
- Join now to see all
Publications & Presentations
PubMed
- Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs.Vivek Narayan, Tao Liu, Yunjie Song, Joshua Mitchell, JoRean Sicks, Ilana Gareen, Lova Sun, Srinivas Denduluri, Ciaran Fisher, Jesse Manikowski, Mark Wojtowicz, Joseph...> ;Journal of the National Comprehensive Cancer Network. 2023 Oct 1
- 103 citationsPhase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.Sarina Anne Piha-Paul, Christine L. Hann, Christopher A. French, Sophie Cousin, Irene Brana, P. A. Cassier, Victor Moreno, Johann S. de Bono, Sara Duckworth Harward, G...> ;JNCI Cancer Spectrum. 2020 Apr 1
- 192 citationsFeatured Updates to the NCCN GuidelinesRobert J. Motzer, Eric Jonasch, M. Dror Michaelson, Lakshminarayanan Nandagopal, John L. Gore, Saby George, Ajjai Alva, Naomi B. Haas, Michael R. Harrison, Elizabeth R...> ;Journal of the National Comprehensive Cancer Network. 2019 Nov 1
- Join now to see all
Press Mentions
Presents State of the Science SummitSeptember 20th, 2017
RCC Advances Shake up Drug ChoicesApril 7th, 2017
Penn Studies Find Promise for Innovations in Liquid BiopsiesMarch 29th, 2017
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
